The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Spike mutation D614G alters SARS-CoV-2 fitness
Open accessPublished version of a preprint
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein substitution D614G became dominant during the coronavirus disease 2019 (COVID-19) pandemic 1,2. However, the effect of this variant on viral spread and vaccine efficacy remains to be defined. Here we engineered the spike D614G substitution in the USA-WA1/2020 SARS-CoV-2 strain, and found that it enhances viral replication in human lung epithelial cells and primary human airway tissues by increasing the infectivity and stability of virions. Hamsters infected with SARS-CoV-2 expressing spike(D614G) (G614 virus) produced higher infectious titres in nasal washes and the trachea, but not in the lungs, supporting clinical evidence showing that the mutation enhances viral loads in the upper respiratory tract of COVID-19 patients and may increase transmission. Sera from hamsters infected with D614 virus exhibit modestly higher neutralization titres against G614 virus than against D614 virus, suggesting that the mutation is unlikely to reduce the ability of vaccines in clinical trials to protect against COVID-19, and that therapeutic antibodies should be tested against the circulating G614 virus. Together with clinical findings, our work underscores the importance of this variant in viral spread and its implications for vaccine efficacy and antibody therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Jessica A et al. [26] studied replication kinetics of the D614G variant in human lung epithelial cell line Calu-3 and found 2.4-fold more infectious virus 36 hpi, indicating enhanced viral replication.”
From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [26]
In the citing paper
“One of the first identified variants includes the D614G mutation in the gene encoding the spike (S) protein, which enhances viral infectivity and shifts S protein conformation toward an angiotensin-converting enzyme 2 (ACE2)-binding fusion-competent state, without significantly modifying sensitivity to antibody neutralization 1,[6][7][8] .”
From Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies (2021) · cites this paper as [7]
In the citing paper
“The D614G mutation is dominant in circulating strains around the world 7,8 .”
From Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera (2021) · cites this paper as [7]
In the citing paper
“The emergence of the common mutation N501Y from different geographical regions, as well as the previously emerged globally dominant D614G mutation, suggest that these mutations might improve viral fitness”
From Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera (2021) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,237
The New Statistics: Why and How
Cumming, G. (2014) · Psychological Science · doi:10.1177/0956797613504966 · Cited by 3,200
HCA Lung Biological Network, Sungnak, W., Huang, N., Bécavin, C., Berg, M., Queen, R., Litvinukova, M., Talavera-López, C., Maatz, H., Reichart, D., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0868-6 · Cited by 2,501
Hoffmann, M., Kleine-Weber, H., & Pöhlmann, S. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.022 · Cited by 1,852
Mulligan, M. J., Lyke, K. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Raabe, V., Bailey, R., Swanson, K. A., et al. (2020) · doi:10.1101/2020.06.30.20142570 · Cited by 1,569
Self-citationSARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
Hou, Y. J., Okuda, K., Edwards, C. E., Martinez, D. R., Asakura, T., Dinnon, K. H., Kato, T., Lee, R. E., Yount, B. L., Mascenik, T. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.042 · Cited by 1,488
Research works printed but not linked: 1
- Mulligan, M. J. et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature 586, 589–593 (2020). · DOI · Paper page
Cited by
Sorted by citations
Items 401–500 of 1,008
Kim, Y., Gaudreault, N. N., Meekins, D. A., Perera, K. D., Bold, D., Trujillo, J. D., Morozov, I., McDowell, C. D., Chang, K., & Richt, J. A. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01789-21 · Cited by 35
Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2Preprint
Sun, S., Gu, H., Cao, L., Chen, Q., Ye, Q., Yang, G., Li, R.-T., Fan, H., Deng, Y., Song, X., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.10.377333 · Cited by 35
Dicken, S. J., Murray, M. J., Thorne, L., Reuschl, A., Forrest, C., Ganeshalingham, M., Muir, L., Kalemera, M. D., Palor, M., McCoy, L. E., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.22.436468 · Cited by 30
Ying, B., Scheaffer, S. M., Whitener, B. M., Liang, C.-Y., Dmytrenko, O., Mackin, S., Wu, K., Lee, D. W., Avena, L. E., Chong, Z., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.07.479419 · Cited by 35
Tasakis, R. N., Samaras, G., Jamison, A., Lee, M., Paulus, A., Whitehouse, G., Verkoczy, L., Papavasiliou, F. N., & Diaz, M. (2021) · PLOS ONE · doi:10.1371/journal.pone.0255169 · Cited by 26
Rodríguez-Maldonado, A. P., Vázquez-Pérez, J. A., Cedro‐Tanda, A., Taboada, B., Boukadida, C., Wong-Arámbula, C. E., Núñez-García, T. E., Cruz-Ortiz, N., Barrera-Badillo, G., Hernández‐Rivas, L., et al. (2021) · Archives of Virology · doi:10.1007/s00705-021-05208-6 · Cited by 32
Neerukonda, S. N., Vassell, R. A., Lusvarghi, S., Wang, R., Echegaray, F., Bentley, L., Eakin, A. E., Erlandson, K. J., Katzelnick, L. C., Weiss, C. D., et al. (2021) · Viruses · doi:10.3390/v13122485 · Cited by 31
Li, J., Jia, H., Tian, M., Wu, N., Yang, X., Qi, J., Ren, W., Li, F., & Bian, H. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.869832 · Cited by 33
Mutation D614G increases SARS-CoV-2 transmission
Arora, P., Pöhlmann, S., & Hoffmann, M. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00502-w · Cited by 34
Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic Sera
Vidal, S. J., Collier, A.-R. Y., Yu, J., McMahan, K., Tostanoski, L. H., Ventura, J. D., Aïd, M., Peter, L. E., Jacob-Dolan, C., Anioke, T., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00404-21 · Cited by 34
Munster, V. J., Flagg, M., Singh, M., Yinda, C. K., Williamson, B. N., Feldmann, F., Pérez-Pérez, L., Schulz, J. E., Brumbaugh, B., Holbrook, M. G., et al. (2021) · Science Advances · doi:10.1126/sciadv.abj3627 · Cited by 34
SARS‐CoV‐2 omicron variant: Could it be another threat?
Shanmugaraj, B., Malla, A., Khorattanakulchai, N., & Phoolcharoen, W. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27532 · Cited by 34
Khairullin, B. M., Zakarya, K. D., Orynbayev, M. B., Abduraimov, Y. O., Kassenov, M., Sarsenbayeva, G., Sultankulova, K. T., Chervyakova, O. V., Myrzakhmetova, B. S., Куралбаевич, Н. А., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101526 · Cited by 36
Ginex, T., Marco‐Marín, C., Wieczór, M., Mata, C. P., Krieger, J., Ruiz-Rodríguez, P., Lopez-Redondo, M., Francés‐Gómez, C., Melero, R., Sorzano, C. Ó. S., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010631 · Cited by 36
SARS-CoV-2 variants: Impact on biological and clinical outcome
Mahilkar, S., Agrawal, S. R., Chaudhary, S., Parikh, S., Sonkar, S. C., Verma, D. K., Chitalia, V., Mehta, D., Koner, B. C., Vijay, N., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.995960 · Cited by 36
Reverse genetic systems of SARS-CoV-2 for antiviral research
Kurhade, C., Xie, X., & Shi, P. (2022) · Antiviral Research · doi:10.1016/j.antiviral.2022.105486 · Cited by 36
Self-citationZhao, Y., Ni, W., Liang, S., Dong, L., Xiang, M., Cai, Z., Niu, D., Zhang, Q., Wang, D., Zheng, Y., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abo3332 · Cited by 34
Ren, W., Ju, X., Gong, M., Lan, J., Yu, Y., Long, Q., Kenney, D., O’Connell, A. K., Zhang, Y. L., Zhong, J., et al. (2022) · mBio · doi:10.1128/mbio.00099-22 · Cited by 40
Trucchi, E., Gratton, P., Mafessoni, F., Motta, S., Cicconardi, F., Mancia, F., Bertorelle, G., D’Annessa, I., & Marino, D. D. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa337 · Cited by 32
A metal ion orients SARS-CoV-2 mRNA to ensure accurate 2′-O methylation of its first nucleotide
Viswanathan, T., Misra, A., Chan, S., Qi, S., Dai, N., Arya, S., Martínez‐Sobrido, L., & Gupta, Y. K. (2021) · Nature Communications · doi:10.1038/s41467-021-23594-y · Cited by 33
Meng, Z., Guo, S., Zhou, Y., Li, M., Wang, M., & Ying, B. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00731-z · Cited by 35
Recent advances and clinical application in point‐of‐care testing of SARS‐CoV‐2
Ye, Q., Lu, D., Zhang, T., Mao, J., & Shang, S. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27617 · Cited by 33
Tabynov, K., Turebekov, N. A., Babayeva, M., Fomin, G., Yerubayev, T., Yespolov, T. I., Li, L., Renukaradhya, G. J., Petrovsky, N., & Tabynov, K. (2022) · npj Vaccines · doi:10.1038/s41541-022-00450-8 · Cited by 33
Singh, P., Mukherji, S., Basak, S., Hoffmann, M., & Das, D. K. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110694 · Cited by 33
Lin, X., Fu, B., Xiong, Y., Xing, N., Xue, W., Guo, D., Zaky, M. Y., Pavani, K. C., Kunec, D., Trimpert, J., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011128 · Cited by 33
Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism
Bills, C. J., Xia, H., Chen, J. Y.-C., Yeung, J., Kalveram, B., Walker, D. H., Xie, X., & Shi, P. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2209208 · Cited by 33
Self-citationCOVID-19 annual update: a narrative review
Biancolella, M., Colona, V. L., Luzzatto, L., Watt, J. L., Mattiuz, G., Conticello, S. G., Kaminski, N., Mehrian‐Shai, R., Ko, A. I., Gonsalves, G., et al. (2023) · Human Genomics · doi:10.1186/s40246-023-00515-2 · Cited by 33
Issa, H., Eid, A. H., Berry, B., Takhviji, V., Khosravi, A., Mantash, S., Nehme, R., Hallal, R., Karaki, H., Dhayni, K., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.620990 · Cited by 30
Possible effects of air temperature on COVID‐19 disease severity and transmission rates
Kang, D., Ellgen, C., & Kulstad, E. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27042 · Cited by 32
Iron dysregulation in COVID‐19 and reciprocal evolution of SARS‐CoV‐2: Natura nihil frustra facit
Gupta, Y., Maciorowski, D., Medernach, B., Becker, D. P., Durvasula, R., Libertin, C. R., & Kempaiah, P. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30207 · Cited by 33
The Alpha Variant (B.1.1.7) of SARS-CoV-2 Failed to Become Dominant in Mexico
Zárate, S., Taboada, B., Muñoz‐Medina, J. E., Iša, P., Sánchez‐Flores, A., Boukadida, C., Herrera‐Estrella, A., Mojica, N. S., Rosales-Rivera, M., Gómez‐Gil, B., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02240-21 · Cited by 31
Inferring the stabilization effects of SARS-CoV-2 variants on the binding with ACE2 receptor
Miotto, M., Rienzo, L. D., Gosti, G., Bo’, L., Parisi, G., Piacentini, R., Boffi, A., Ruocco, G., & Milanetti, E. (2022) · Communications Biology · doi:10.1038/s42003-021-02946-w · Cited by 32
Cocherie, T., Zafilaza, K., Leducq, V., Marot, S., Cálvez, V., Marcelin, A., & Todesco, È. (2022) · Microorganisms · doi:10.3390/microorganisms11010030 · Cited by 33
Kuzmina, A., Wattad, S., Khalaila, Y., Ottolenghi, A., Rosental, B., Engel, S., Rosenberg, E., & Taube, R. (2021) · iScience · doi:10.1016/j.isci.2021.103467 · Cited by 33
Liu, X., Mostafavi, H., Ng, W. H., Freitas, J. R., King, N. J. C., Zaid, A., Taylor, A., & Mahalingam, S. (2022) · mBio · doi:10.1128/mbio.00683-22 · Cited by 31
Caì, Y., Diallo, S., Rosenthal, K., Ren, K., Flores, D. J., Dippel, A. B., Oganesyan, V., van Dyk, N., Chen, X., Cantu, E. N., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.ado2817 · Cited by 31
Antigenic variation of SARS‐CoV‐2 in response to immune pressure
Forni, D., Cagliani, R., Pontremoli, C., Mozzi, A., Pozzoli, U., Clerici, M., & Sironi, M. (2020) · Molecular Ecology · doi:10.1111/mec.15730 · Cited by 30
Phylogenomic analysis of COVID-19 summer and winter outbreaks in Hong Kong: An observational study
Chan, W.-M., Ip, J. D., Chu, A. W., Tse, H., Tam, A. R., Li, X., Kwan, M. Y. W., Yau, Y.-S., Leung, W.-S., Chik, T. S., et al. (2021) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2021.100130 · Cited by 31
Analysis of Key Factors of a SARS-CoV-2 Vaccination Program: A Mathematical Modeling Approach
Martínez‐Rodríguez, D., González‐Parra, G., & Villanueva, R. J. (2021) · Epidemiologia · doi:10.3390/epidemiologia2020012 · Cited by 32
Chaintoutis, S. C., Siarkou, V. I., Mylonakis, M. E., Kazakos, G. M., Skeva, P., Bampali, M., Dimitriou, M., Dovrolis, N., Polizopoulou, Z. S., Karakasiliοtis, I., et al. (2021) · Transboundary and Emerging Diseases · doi:10.1111/tbed.14132 · Cited by 31
Yu, D., Zhu, Y., Jiao, T., Wu, T. T., Xiao, X., Qin, B., Chong, H., Lei, X., Ren, L., Cui, S., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1937329 · Cited by 32
Olsen, R. J., Christensen, P. A., Long, S. W., Subedi, S., Hodjat, P., Olson, R., Nguyen, M., Davis, J. J., Yerramilli, P., Saavedra, M. O., et al. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.07.002 · Cited by 30
Pan, X., Shi, J. R., Hu, X., Wu, Y. L., Zeng, L., Yao, Y., Shang, W., Liu, K., Gao, G., Guo, W., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00320-y · Cited by 30
Rapid detection of multiple SARS-CoV-2 variants of concern by PAM-targeting mutations
Ning, B., Youngquist, B. M., Li, D. D., Lyon, C. J., Zelazny, A. M., Maness, N. J., Tian, D., & Hu, Y. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100173 · Cited by 29
Riccio, A., Santopolo, S., Rossi, A., Piacentini, S., Rossignol, J., & Santoro, M. G. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04246-w · Cited by 29
Abebe, E. C., Medhin, M. T. G., T/Mariam, A. B., Dejenie, T. A., Ayele, T. M., Admasu, F. T., Muche, Z. T., & Adela, G. A. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s360103 · Cited by 31
Photonics enabled intelligence system to identify SARS-CoV 2 mutations
Taha, B. A., Al-Jubouri, Q., Mashhadany, Y. I. M. A., Zan, M. S. D., Bakar, A. A. A., Fadhel, M. M., & Arsad, N. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-11930-1 · Cited by 32
Hossen, M. L., Baral, P., Sharma, T. K., Gerstman, B. S., & Chapagain, P. P. (2022) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp00169a · Cited by 29
Troyano-Hernáez, P., Reinosa, R., & Holguín, Á. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126394 · Cited by 32
The NSP4 T492I mutation increases SARS-CoV-2 infectivity by altering non-structural protein cleavage
Lin, X., Sha, Z., Trimpert, J., Kunec, D., Jiang, C., Xiong, Y., Xu, B., Zhu, Z., Xue, W., & Wu, H. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.06.002 · Cited by 32
Alpha-1-antitrypsin and its variant-dependent role in COVID-19 pathogenesisPreprint
Stevens, C. S., Oguntuyo, K. Y., Kowdle, S., Brambilla, L., Haas, G. D., Gowlikar, A., Siddiquey, M. N. A., Schilke, R. M., Woolard, M. D., Zhang, H., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.14.248880 · Cited by 33
Touret, F., Lucıanı, L., Baronti, C., Cochin, M., Driouich, J., Gilles, M., Thirion, L., Nougaırède, A., & de Lamballerie, X. N. (2021) · mBio · doi:10.1128/mbio.00850-21 · Cited by 29
Miao, M., Clercq, E. D., & Li, G. (2021) · Biomedicines · doi:10.3390/biomedicines9040412 · Cited by 32
Padhi, A. K., Dandapat, J., Saudagar, P., Uversky, V. N., & Tripathi, T. (2021) · FEBS Letters · doi:10.1002/1873-3468.14182 · Cited by 29
Nanopore sequencing of SARS-CoV-2: Comparison of short and long PCR-tiling amplicon protocols
Brejová, B., Boršová, K., Hodorová, V., Čabanová, V., Gafurov, A., Fričová, D., Neboháčová, M., Vinař, T., Klempa, B., & Nosek, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259277 · Cited by 31
Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
Hijikata, A., Shionyu‐Mitsuyama, C., Nakae, S., Shionyu, M., Ota, M., Kanaya, S., Hirokawa, T., Nakajima, S., Watashi, K., & Shirai, T. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13337 · Cited by 30
The Runaway Evolution of SARS-CoV-2 Leading to the Highly Evolved Delta Strain
Ruan, Y., Hou, M., Tang, X., He, X., Lu, X., Lü, J., Wu, C., & Wen, H. (2022) · Molecular Biology and Evolution · doi:10.1093/molbev/msac046 · Cited by 29
Cahyani, I., Putro, E. W., Ridwanuloh, A. M., Wibowo, S. H. B., Hariyatun, H., Syahputra, G., Akbariani, G., Utomo, A. R. H., Ilyas, M., Loose, M., et al. (2022) · Viruses · doi:10.3390/v14040778 · Cited by 30
Chen, D. W., Turcinovic, J., Feng, S., Kenney, D., Chin, C. V., Choudhary, M. C., Conway, H. L., Semaan, M., Close, B. J., Tavares, A. H., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106634 · Cited by 30
Gorman, M. J., Patel, N., Guebre‐Xabier, M., Zhu, A. L., Atyeo, C. G., Pullen, K. M., Loos, C., Goez-Gazi, Y., Carrion, R., Tian, J.-H., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.05.429759 · Cited by 29
Proteases and variants: context matters for SARS-CoV-2 entry assays
Stevens, C. S., Oguntuyo, K. Y., & Lee, B. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.07.004 · Cited by 28
The Mutational Landscape of SARS-CoV-2
Saldivar‐Espinoza, B., Garcia‐Segura, P., Novau-Ferré, N., Macip, G., Martínez, R., Puigbò, P., Cereto‐Massagué, A., Pujadas, G., & Garcı́a-Vallvé, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109072 · Cited by 30
Structural Immunology of SARS ‐ CoV ‐2
Yuan, M., & Wilson, I. A. (2024) · Immunological Reviews · doi:10.1111/imr.13431 · Cited by 29
Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets
Romeo, I., Mesiti, F., Lupia, A., & Alcaro, S. (2021) · Molecules · doi:10.3390/molecules26030632 · Cited by 30
Li, R., Ma, X., Deng, J., Chen, Q., Liu, W., Peng, Z., Qiao, Y., Lin, Y., He, X., & Zhang, H. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00641-8 · Cited by 29
Developing effective siRNAs to reduce the expression of key viral genes of COVID-19
Wu, R., & Luo, K. Q. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59151 · Cited by 28
Giovanetti, M., Cella, E., Benedetti, F., Magalis, B. R., Fonseca, V., Fabris, S., Campisi, G., Ciccozzi, A., Angeletti, S., Borsetti, A., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02025-0 · Cited by 29
Molina-Mora, J. A., Cordero-Laurent, E., Godínez, A., Calderón-Osorno, M., Brenes, H., Soto-Garita, C., Pérez-Corrales, C., Rica, C.-C. C. I. D. E. G. D. S.-C.-2. C., Drexler, J. F., Moreira‐Soto, A., et al. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104872 · Cited by 29
Machado, D. J., Scott, R., Guirales-Medrano, S., & Janies, D. A. (2021) · Cladistics · doi:10.1111/cla.12454 · Cited by 31
Renn, M., Bartok, E., Zillinger, T., Hartmann, G., & Behrendt, R. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107931 · Cited by 28
Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2
Castonguay, N., Zhang, W., & Langlois, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.676314 · Cited by 28
SARS-CoV-2 viral RNA levels are not 'viral load'
Michalakis, Y., Sofonea, M. T., Alizon, S., & Bravo, I. G. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.08.008 · Cited by 29
Chen, H.-Y., Huang, C., Tian, L., Huang, X., Zhang, C., Llewellyn, G. N., Rogers, G. L., Andresen, K., O’Gorman, M. R. G., Chen, Y., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00966-21 · Cited by 31
Self-resetting molecular probes for nucleic acids detection enabled by fuel dissipative systems
Li, N., Zhao, Y., Liu, Y., Yin, Z., Liu, R., Zhang, L., Ma, L., Dai, X., Zhou, D., & Su, X. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101308 · Cited by 29
Self-citationThe Spike Protein of SARS-CoV-2 Is Adapting Because of Selective Pressures
López-Cortés, G. I., Palacios-Pérez, M., Veledíaz, H. F., Hernández-Aguilar, M. M., López-Hernández, G. R., Zamudio, G. S., & José, M. V. (2022) · Vaccines · doi:10.3390/vaccines10060864 · Cited by 26
Photodynamic viral inactivation assisted by photosensitizers
Sadraeian, M., Zhang, L., Aavani, F., Biazar, E., & Jin, D. (2022) · Materials Today Physics · doi:10.1016/j.mtphys.2022.100882 · Cited by 29
Ghufran, M., Ullah, M., Khan, H. A., Ghufran, S., Ayaz, M., Siddiq, M., Abbas, S. Q., Hassan, S. S. U., & BUNGAU, S. G. (2023) · Bioengineering · doi:10.3390/bioengineering10010100 · Cited by 29
Rapid characterization of a Delta-Omicron SARS-CoV-2 recombinant detected in EuropePreprint
Simon‐Lorière, E., Montagutelli, X., Lemoine, F., Donati, F., Touret, F., Bourret, J., Prot, M., Munier, S., Attia, M., Conquet, L., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1502293/v1 · Cited by 29
A Biochemical Perspective of the Nonstructural Proteins (NSPs) and the Spike Protein of SARS CoV-2
Yoshimoto, F. K. (2021) · The Protein Journal · doi:10.1007/s10930-021-09967-8 · Cited by 28
Identifying Primate ACE2 Variants That Confer Resistance to SARS-CoV-2
Bhattacharjee, M. J., Lin, J.-J., Chang, C.-Y., Chiou, Y.-T., Li, T., Tai, C.-W., Shiu, T.-F., Chen, C., Chou, C.-Y., Chakraborty, P., et al. (2021) · Molecular Biology and Evolution · doi:10.1093/molbev/msab060 · Cited by 28
Evolution, Ecology, and Zoonotic Transmission of Betacoronaviruses: A Review
Jelinek, H. F., Mousa, M., Alefishat, E. A., Osman, W. M., Spence, I., Bu, D., Feng, S. F., Byrd, J. H., Magni, P. A., Sahibzada, S., et al. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.644414 · Cited by 28
Respiratory Co-Infections: Modulators of SARS-CoV-2 Patients’ Clinical Sub-Phenotype
Mehta, P., Sahni, S., Siddiqui, S., Mishra, N., Sharma, P., Sharma, S., Tyagi, A., Chattopadhyay, P., Vivekanand, A., Devi, P., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.653399 · Cited by 28
The virological impacts of SARS-CoV-2 D614G mutation
Wang, C., Zheng, Y. Y., Niu, Z., Jiang, X., & Sun, Q. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab045 · Cited by 29
Timing of exposure is critical in a highly sensitive model of SARS-CoV-2 transmission
Ganti, K., Ferreri, L. M., Lee, C.-Y., Bair, C. R., Delima, G. K., Holmes, K. E., Suthar, M. S., & Lowen, A. C. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010181 · Cited by 28
Profiling of SARS-CoV-2 Subgenomic RNAs in Clinical Specimens
Chen, Z., Ng, R. W. Y., Lui, G. C.-Y., Ling, L., Chow, C., Yeung, A. C. M., Boon, S. S., Wang, M. H., Chan, K. C. C., Chan, R. W. Y., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00182-22 · Cited by 28
de Souza, A. S., Amorim, V. M. D. F., Guardia, G. D. A., dos Santos, F. F., Ulrich, H., Galante, P. A. F., de Souza, R. F., & Guzzo, C. R. (2022) · Viruses · doi:10.3390/v14040827 · Cited by 28
Challenges of vaccination and herd immunity in COVID‐19 and management strategies
She, J., Hou, D., Chen, C., Bi, J., & Song, Y. (2022) · The Clinical Respiratory Journal · doi:10.1111/crj.13543 · Cited by 28
Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters
Boon, A. C. M., Darling, T. L., Halfmann, P., Franks, J., Webby, R. J., Barouch, D. H., Port, J. R., Munster, V. J., Diamond, M., & Kawaoka, Y. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010970 · Cited by 23
Christie, S. M., Tada, T., Yin, Y., Bhardwaj, A., Landau, N. R., & Rothenberg, E. (2022) · Science Advances · doi:10.1126/sciadv.abo3977 · Cited by 28
Decreased Interfacial Dynamics Caused by the N501Y Mutation in the SARS-CoV-2 S1 Spike:ACE2 Complex
Ahmed, W. S., Philip, A. M., & Biswas, K. H. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.846996 · Cited by 28
How SARS-CoV-2 first adapted in humans
Choe, H., & Farzan, M. (2021) · Science · doi:10.1126/science.abi4711 · Cited by 27
Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development
Günl, F., Mecate-Zambrano, A., Rehländer, S., Hinse, S., Ludwig, S., & Brunotte, L. (2021) · Vaccines · doi:10.3390/vaccines9101052 · Cited by 27
Estofolete, C. F., Banho, C. Á., Campos, G. R. F., Marques, B. D. C., Sacchetto, L., Ullmann, L. S., Possebon, F. S., Machado, L. F., Syrio, J. D., Araújo, J. P., et al. (2021) · Viruses · doi:10.3390/v13071237 · Cited by 27
Huang, S., Miller, S. O., Yen, C., & Wang, S. (2020) · Genes · doi:10.3390/genes12010016 · Cited by 27
SARS-CoV-2 Main Protease Active Site Ligands in the Human Metabolome
Sardanelli, A. M., Isgrò, C., & Palese, L. L. (2021) · Molecules · doi:10.3390/molecules26051409 · Cited by 28
SARS-CoV-2: Origin, Evolution, and Targeting Inhibition
Ning, S., Yu, B., Wang, Y., & Wang, F. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.676451 · Cited by 28
Decomposing the sources of SARS-CoV-2 fitness variation in the United States
Kepler, L. M., Hamins-Puértolas, M., & Rasmussen, D. A. (2021) · Virus Evolution · doi:10.1093/ve/veab073 · Cited by 24
Jaworski, E. A., Langsjoen, R. M., Mitchell, B. M., Judy, B. M., Newman, P. C., Plante, J. A., Plante, K. S., Miller, A. L., Zhou, Y., Swetnam, D. M., et al. (2021) · eLife · doi:10.7554/elife.68479 · Cited by 25
Self-citationAge-Related Susceptibility of Ferrets to SARS-CoV-2 Infection
Martins, M., Fernandes, M. H. V., Joshi, L. R., & Diel, D. G. (2021) · Journal of Virology · doi:10.1128/jvi.01455-21 · Cited by 26
Suratekar, R., Ghosh, P., Niesen, M. J. M., Donadio, G., Anand, P., Soundararajan, V., & Venkatakrishnan, A. (2022) · Molecular Systems Biology · doi:10.15252/msb.202110673 · Cited by 28
Metadata
- Authors
- Plante, J. A., Liu, Y., Liu, J., Xia, H., Johnson, B. A., Lokugamage, K. G., Zhang, X., Muruato, A. E., Zou, J., Fontes-Garfias, C. R., Mirchandani, D., Scharton, D., Bilello, J. P., Ku, Z., An, Z., Kalveram, B., Freiberg, A. N., Menachery, V. D., Xie, X., Plante, K. S., Weaver, S. C., & Shi, P.-Y.
- Affiliations
- The University of Texas Medical Branch at Galveston (US)
- Gilead Sciences (United States) (US)
- Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (US)
- Corresponding author
- Xie, Xuping
- Plante, Kenneth S.
- Weaver, Scott C.
- Shi, Pei-Yong
- ORCID
- Venue
- Nature
- Published
- 2020-10-26
- Volume
- 592
- Issue
- 7852
- Pages
- 116-121
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC8158177
- OpenAlex
- W3093768302
- Cited by
- 1,558
- References
- 37
- Citations by year
- 2026: 37 · 2025: 73 · 2024: 120 · 2023: 174 · 2022: 427 · 2021: 670 · 2020: 55
- FWCI
- 43.60
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-06-15)
- Open access
- bronze
- doi.org
- Locations
- Nature (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- PubMed Central (submittedVersion, cc-by-nc-nd)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Amon G. Carter Foundation
- John S. Dunn Foundation (AI145617)
- University of Texas System
- Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (AI134907)
- National Institutes of Health (AG049042, TL1TR001440, AI145617, AI142759, UL1TR001439)
- National Institute on Aging (AI142759, AG049042, R00AG049092)
- National Institute of Allergy and Infectious Diseases (R43AI145617, AI142759, R24AI120942, R01AI134907, R21AI145400, U01AI151801, U19AI142759, R01AI153602, AI153602, AG049042, AI134907, AI145617, UC7AI094660)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, viral fitness, viral replication, upper respiratory tract infection, virus transmission, neutralizing antibodies, vaccine efficacy, hamster model, lung epithelial cells, therapeutic antibodies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
